CircRARS that bind to IGF2BP3 in ccRCC promote ccRCC progression by maintaining the stability of downstream m6A-modified target molecules, such as CAPN15, CD44, HMGA2, TNRC6A, and ZMIZ2 [139]. This evidence concerns the gene HMGA2 and nonpapillary renal cell carcinoma.